4,360
Views
18
CrossRef citations to date
0
Altmetric
Review Article

Critical laboratory values in hemostasis: toward consensus

, , , &
Pages 455-461 | Received 26 Oct 2016, Accepted 29 Dec 2016, Published online: 10 Feb 2017

References

  • Plebani M, Favaloro EJ, Lippi G. Patient safety and quality in laboratory and hemostasis testing: a renewed loop? Semin Thromb Hemost. 2012;38:553–8.
  • Lippi G, Favaloro EJ, Plebani M. Quality in hemostasis and thrombosis – part IV. Semin Thromb Hemost. 2015;41:263.
  • Adcock DM, Favaloro EJ, Lippi G. Critical pre-examination variables in the hemostasis laboratory and their quality indicators. Clin Biochem. 2016;49:1315–20.
  • Piva E, Plebani M. From “panic” to “critical”: which path toward harmonization? Clin Chem Lab Med. 2013;51:2069–71.
  • Sciacovelli L, Aita A, Padoan A, Pelloso M, Antonelli G, Piva E, et al. Performance criteria and quality indicators for the post-analytical phase. Clin Chem Lab Med. 2016;54:1169–76.
  • Lundberg G. When to panic over an abnormal value. Med Lab Obs. 1972;4:47–54.
  • Joint Commission. 2016 National Patient Safety Goals 2016. [cited 2016 Oct 21]. Available from: https://www.jointcommission.org/hap_2016_npsgs/
  • Clinical and Laboratory Standards Institute (CLSI). Management of Critical- and Significant-Risk Results. 1st ed. CLSI guideline GP47. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, PA, USA, 2015.
  • Campbell C, Caldwell G, Coates P, Flatman R, Georgiou A, Horvath AR, et al. Consensus statement for the management and communication of high risk laboratory results. Clin Biochem Rev. 2015;36:97–105.
  • Lippi G, Plebani M, Favaloro EJ. The changing face of hemostasis testing in modern laboratories: consolidation, automation, and beyond. Semin Thromb Hemost. 2015;41:294–9.
  • Pasalic L, Favaloro EJ. The new and the old of heparin-induced thrombocytopenia. Clin Chem Lab Med. 2015;53:149–52.
  • Favaloro EJ. Laboratory testing in disseminated intravascular coagulation. Semin Thromb Hemost. 2010;36:458–67.
  • Tiede A, Werwitzke S, Scharf RE. Laboratory diagnosis of acquired hemophilia A: limitations, consequences, and challenges. Semin Thromb Hemost. 2014;40:803–11.
  • Marlar RA, Clement B, Gausman J. Activated partial thromboplastin time monitoring of unfractionated heparin therapy: issues and recommendations. Semin Thromb Hemost. 2016. [Epub ahead of print]. doi: 10.1055/s-0036-1581128
  • Danese E, Montagnana M, Lippi G. Factor XII in hemostasis and thrombosis: active player or (innocent) bystander? Semin Thromb Hemost. 2016;42:682–8.
  • Dighe AS, Rao A, Coakley AB, Lewandrowski KB. Analysis of laboratory critical value reporting at a large academic medical center. Am J Clin Pathol. 2006;125:758–64.
  • Guzmán DAM, Solari SS, Lagos LM, Poggi MH, Sánchez PT, Madrid QA, et al. Laboratory alert value reporting by the clinical laboratory at an academic medical network. Rev Med Chil. 2009;137:1137–44.
  • Yang D, Zhou Y, Yang C. Analysis of laboratory repeat critical values at a large tertiary teaching hospital in China. PLoS One. 2013;8:e59518.
  • Piva E, Pelloso M, Penello L, Plebani M. Laboratory critical values: automated notification supports effective clinical decision making. Clin Biochem. 2014;47:1163–8.
  • Doering TA, Plapp F, Crawford JM. Establishing an evidence base for critical laboratory value thresholds. Am J Clin Pathol. 2014;142:617–28.
  • Howanitz PJ, Darcy TP, Meier FA, Bashleben CP. Assessing clinical laboratory quality: a College of American Pathologists Q-Probes Study of Prothrombin Time INR Structures, Processes, and Outcomes in 98 Laboratories. Arch Pathol Lab Med. 2015;139:1108–14.
  • Tripodi A, Lippi G, Plebani M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med. 2016;54:215–22.
  • Wagar EA, Friedberg RC, Souers R, Stankovic AK. Critical values comparison: a College of American Pathologists Q-Probes survey of 163 clinical laboratories. Arch Pathol Lab Med. 2007;131:1769–75.
  • Pai M, Moffat KA, Plumhoff E, Hayward CP. Critical values in the coagulation laboratory: results of a survey of the North American Specialized Coagulation Laboratory Association. Am J Clin Pathol. 2011;136:836–41.
  • Tillman J, Barth JH. ACB National Audit Group. A survey of laboratory ‘critical (alert) limits’ in the UK. Ann Clin Biochem. 2003;40:181–4.
  • Campbell CA, Georgiou A, Westbrook JI, Horvath AR. What alert thresholds should be used to identify critical risk results: a systematic review of the evidence. Clin Chem. 2016;62:1445–57.
  • Thomas L. Critical limits of laboratory results for urgent clinician notification. eJIFCC. 2003;14:1–8.
  • Piva E, Sciacovelli L, Laposata M, Plebani M. Assessment of critical values policies in Italian institutions: comparison with the US situation. Clin Chem Lab Med. 2010;48:461–8.
  • Kopcinovic LM, Trifunović J, Pavosevic T, Nikolac N. Croatian survey on critical results reporting. Biochem Med (Zagreb). 2015;25:193–202.
  • Lippi G, Mattiuzzi C. Critical laboratory values communication: summary recommendations from available guidelines. Ann Transl Med. 2016;4:400.
  • Lippi G, Bonfanti L, Saccenti C, Cervellin G. Causes of elevated D-dimer in patients admitted to a large urban emergency department. Eur J Intern Med. 2014;25:45–8.
  • Lippi G, Cervellin G, Casagranda I, Morelli B, Testa S, Tripodi A. D-dimer testing for suspected venous thromboembolism in the emergency department. Consensus document of AcEMC, CISMEL, SIBioC, and SIMeL. Clin Chem Lab Med. 2014;52:621–8.
  • Kristoffersen AH, Ajzner E, Rogic D, Sozmen EY, Carraro P, Faria AP, et al. Is D-dimer used according to clinical algorithms in the diagnostic work-up of patients with suspicion of venous thromboembolism? A study in six European countries. Thromb Res. 2016;142:1–7.
  • Longstaff C, Adcock D, Olson JD, Jennings I, Kitchen S, Mutch N, et al. Harmonisation of D-dimer – a call for action. Thromb Res. 2016;137:219–20.
  • Lippi G, Tripodi A, Simundic AM, Favaloro EJ. International survey on D-dimer test reporting: a call for standardization. Semin Thromb Hemost. 2015;41:287–93.
  • Ricós C, Cava F, García-Lario JV, Hernández A, Iglesias N, Jiménez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest. 2004;64:175–84.
  • Lippi G, Salvagno GL, Adcock DM, Gelati M, Guidi GC, Favaloro EJ. Right or wrong sample received for coagulation testing? Tentative algorithms for detection of an incorrect type of sample. Int J Lab Hematol. 2010;32:132–8.
  • Ajzner É, Rogic D, Meijer P, Kristoffersen AH, Carraro P, Sozmen E, et al. An international study of how laboratories handle and evaluate patient samples after detecting an unexpected APTT prolongation. Clin Chem Lab Med. 2015;53:1593–603.
  • Kristoffersen AH, Thue G, Ajzner E, Claes N, Horvath AR, Leonetti R, Kallion K, et al. Interpretation and management of INR results: a case history based survey in 13 countries. Thromb Res. 2012;130:309–15.
  • Tobian AA, Heddle NM, Wiegmann TL, Carson JL. Red blood cell transfusion: 2016 clinical practice guidelines from AABB. Transfusion. 2016;56:2627–30.
  • Lam Q, Ajzner E, Campbell CA, Young A. Critical risk results – an update on international initiatives. Ejifcc. 2016;27:66–76.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.